FDA warns Gilead over 'misleading' paid search link

The FDA warned Gilead ($GILD) about a paid search link for its drug Viread with the title "Hepatitis B Prevention." The drug is approved for treating--not preventing--hepatitis B, prompting FDA to call the advert misleading. FDA was also critical of the lack of risk information. Article | Letter (PDF)

Suggested Articles

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

Elligo Health Research will test a harmonized real-word data model built by the FDA.

Just about a year after filing its IPO application BGI hits a big wall with a regulatory review.